DMII

NASDAQ 已收盘

Drugs Made In America Acquisition II

10.25 USD
▲+0.02+0.20%
盘后 10.26 +0.10%
2026-11-19
市值
$651.65M
市盈率
36.85
EPS
0.24
股息率
—
52 周区间
9.86 – 10.33
成交量
27.95K
Beta
—
目标价
—
52W 低 9.8652W 高 10.33
价格走势

公司简介

Drugs Made In America Acquisition II Corp. does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. It intends to source and evaluate companies focused on the pharmaceutical sector. Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in New York, New York.